top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Pertussis


Testing

  • PCR: Best ≤3 weeks from cough onset; sensitivity ↓ after antibiotics or >3 weeks

  • Serology: Optimal after 2 weeks, up to 12 weeks (ideal <8 weeks)

____________________________________


Timing & Treatment

  • Effective Treatment: ≤3 weeks of cough onset; reduces transmission but not disease if delayed

  • Cough Duration: Up to 3 months, with prolonged convalescence

____________________________________


Antibiotics

  • First-Line:

    • Azithromycin: 500 mg OD (Day 1), 250 mg OD (Days 2–5)

    • Clarithromycin: 500 mg BD for 7 days

  • Alternative:

    • TMP-SMX: Adults: 160+800 mg BD; Kids >1 month: 4+20 mg/kg BD (max 160+800 mg) for 7 days

    • Neonates: Azithromycin 10 mg/kg OD for 5 days

  • Notes: Avoid roxithromycin; erythromycin poorly tolerated

____________________________________


Diagnosis

  • Cause: Bordetella pertussis

  • Symptoms: Cough >2 weeks + paroxysms, whoop, or post-tussive vomiting

  • Adults/Kids: Persistent, non-specific cough possible

  • Notification: Mandatory to public health authorities

____________________________________


Prevention

  • Prophylaxis:

    • Who: Infants <6 months, pregnant women, high-risk contacts

    • Antibiotics: Same as treatment, start ≤14 days post-exposure

  • Vaccination:

    • Maternal: 20–32 weeks gestation

    • dTpa boosters for adolescents/adults in close contact with infants

  • Public Health:

    • Isolate ≥5 days after starting antibiotics

    • Untreated: Infectious for 21 days post-cough onset

____________________________________


Notes

  • Reinforce hand hygiene, cough etiquette

  • Consider pertussis in prolonged cough, especially if vaccination incomplete

Bookmark Failed!

Bookmark Saved!

bottom of page